(IN BRIEF) Philips has introduced Titanion MR, a new ultra-high-gradient 3.0T MRI system designed to support advanced quantitative imaging and biomarker development across the body. Unveiled at ISMRM 2026, the system combines ultra-high gradient performance with AI-powered software to improve … Read the full press release
Posted in Artificial Intelligence (AI), Austria, Business, Electronics & Machinery, Healthcare, Industrial, Netherlands, Science, Technology
Tagged 3.0T MRI, AI-powered imaging, artificial intelligence, clinical imaging, diagnostic imaging, diffusion imaging, healthcare AI, healthcare technology, imaging biomarkers, Ioannis Panagiotelis, ISMRM 2026, magnetic resonance imaging, medical technology, microstructural imaging, MRI innovation, MRI technology, neurodegenerative diseases, New Philips Titanion MRI Platform Combines Ultra-High Gradient Technology with AI-Powered Imaging Workflows, oncology imaging, personalized medicine, Philips, Philips Introduces Titanion MR to Advance Quantitative Imaging and Whole-Body Biomarker Development, quantitative imaging, radiology, SmartSpeed Precise, Titanion MR, whole-body imaging
(IN BRIEF) Evotec SE announced it has received a US$ 25 million payment from Bristol Myers Squibb, marking progress in their joint neuroscience partnership focused on neurodegenerative diseases. The milestone payment will further advance the companies’ preclinical pipeline and research … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, Science, Technology
Tagged biotechnology, BMS-986419, Bristol-Myers Squibb, clinical trials, Cord Dohrmann, disease-modifying therapies, drug discovery, Evotec and Bristol Myers Squibb Advance Neuroscience Collaboration with New Funding Milestone, Evotec SE, EVT8683, milestone payment, neurodegenerative diseases, neuroscience, neuroscience collaboration, neuroscience research, pharmaceutical innovation, preclinical research, strategic partnership, translational medicine
(IN BRIEF) Luxembourg marked the tenth anniversary of the National Centre for Excellence in Research on Parkinson’s Disease (NCER-PD) with a two-day symposium highlighting a decade of progress in Parkinson’s research, clinical care, and prevention. Funded by the National Research … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Technology
Tagged biomarkers, Centre Hospitalier de Luxembourg, FNR, Healthcare Innovation, Integrated BioBank of Luxembourg, Laboratoire National de Santé, Luxembourg Celebrates Ten Years of Groundbreaking Parkinson’s Research Through NCER-PD Symposium, Luxembourg Centre for Systems Biomedicine, Luxembourg Institute of Health, Luxembourg research, NCER-PD, NCER-PD Marks Ten Years of Parkinson’s Breakthroughs with Global Research Symposium in Luxembourg, neurodegenerative diseases, Parkinson's disease, precision medicine, prevention, Rejko Krüger, Rudi Balling, Stéphanie Obertin, symposium, translational research, University of Luxembourg
(IN BRIEF) A team at the Technical University of Munich has developed synthetic macrocyclic peptides that inhibit harmful protein aggregation linked to Parkinson’s disease. The peptides also block the interactions between proteins involved in Alzheimer’s and type 2 diabetes, which … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Alzheimer’s disease, amyloid plaques, Aphrodite Kapurniotu, biomedicine research, cross-seeding inhibition, DFG, EPFL, German Research Foundation, Helmholtz Center Munich, LMU University Hospital, macrocyclic peptides, metabolic disorders, multifunctional drugs, neurodegenerative diseases, Parkinson's disease, peptide biochemistry, protein aggregation, SFB 1035, synthetic peptides, Technical University of Munich, TUM, type 2 diabetes
(IN BRIEF) Dr Amanda Pearce of Loughborough University has received a substantial grant from the Academy of Medical Sciences as part of the Springboard programme, which supports 62 early-career researchers across the UK with awards ranging from £100,000 to £125,000. … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, Alzheimer’s disease, blood-brain barrier, career development, CRISPR/Cas9 therapy, dementia, DNA modification, Dr Amanda Pearce, early-career researchers, fluorescent polymer nanoparticles, Healthcare Innovation, leadership, Loughborough University, mentoring, neurodegenerative diseases, NHS burden, research funding, Springboard programme, UK science
(IN BRIEF) Researchers at TU Delft, led by Angelo Accardo, have developed a groundbreaking 3D-printed model that replicates the brain’s environment to study how neurons grow and form networks. Using nanopillar arrays, the team mimicked the mechanical and geometric properties … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged 3D-printed model, Advanced Functional Materials, Alzheimer's, Angelo Accardo, applied physics, autism, brain tissue, brain-like environment, ErasmusMC, extracellular matrix, growth cones, mechanical engineering, nanopillar arrays, network formation, neurodegenerative diseases, neurological disorders, neuron growth, neuron maturation, neurons, neuroscience, Parkinson's, RESEARCH, scientific innovation, TU Delft, two-photon polymerization
Cordoba, Spain, 12-6-2013 — /europawire.eu/ — VivaCell Biotechnology España S.L., Cordoba, Spain today announced that it has entered into joint Research Collaboration and Commercialization Agreements with Aphios Corporation, USA, to develop therapeutics for multiple sclerosis and other neurodegenerative diseases of the central … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Spain
Tagged Aphios Corporation, biotech company, biotech development, biotech pharma companies, biotechnology, cannabinoid receptor, cannabinoids, central nervous system, CNS and neurological disorders, Cordoba, endocannabinoid system, multiple sclerosis, neurodegenerative diseases, novel class of compounds, therapeutics for multiple sclerosis, VivaCell Biotechnology, VivaCell Biotechnology España S.L.
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?